Blood test may predict prostate cancer treatment success

NCT ID NCT03408964

First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 21 times

Summary

This study is looking for markers in the blood that might help doctors predict how well a prostate cancer patient will respond to treatment. Researchers will collect blood samples from 600 men at different stages of prostate cancer and analyze them for certain biomarkers. The goal is to see if these markers can give useful information beyond the standard PSA test. No new treatments are being tested; this is purely an observational study to gather knowledge.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oncology Institute of Southern Switzerland (IOSI)

    RECRUITING

    Bellinzona, 6500, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.